The Food and Drug Administration has laid out biosimilar promotion guidelines. The agency is working with the Federal Trade Commission to ensure companies don’t use anticompetitive practices to stall the biosimilar market. (MM&M)

Regeneron has partnered with Health and Human Services on a coronavirus vaccine. The company previously partnered with HHS to develop an Ebola vaccine. J&J, GSK, Gilead and Moderna are also developing a vaccine. (Reuters)

January drug price increases show a slowing rate of inflation. Pharma companies increased prices an average of 5% this month, the lowest since 2014. Analysts said the slowing increase is likely due to payer and public pressure. (BioPharma Dive)

The FDA has reviewed testing methods of asbestos in talc. The hearing occurred after a test found asbestos in Johnson & Johnson’s baby powder products. The FDA is looking for more reliable ways to test talc products. (Reuters)

Bristol-Myers Squibb has launched a new biotech with BioMotiv. The company, Anteros Pharmaceuticals, focuses on creating inflammation and fibrosis medicines. BMS and BioMotiv began their partnership in September. (BioPharma Dive)